| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |